FDMT
4D Molecular Therapeutics Inc
15.00$
-5.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
4D Molecular Therapeutics Inc (FDMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -70 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.2 | -25 | -29 | -30 | -29 | -46 | -48 | -43 | -46 | 29 | -68 | -70 | -156 | |
| 1.4 | 1.5 | 1.6 | 1.6 | 1.7 | 1.8 | 1.8 | 1.9 | 2.0 | 2.0 | 2.1 | 0.5 | 6.5 | |
| 4.6 | 5.9 | 6.0 | 6.1 | 6.5 | 7.6 | 7.0 | 5.0 | 4.5 | 5.6 | 4.5 | 5.9 | 20 | |
| 3.1 | 0.7 | -3.5 | -0.7 | 8.5 | -3.7 | -7.2 | 5.6 | 5.0 | 2.8 | -4.8 | -3.6 | -0.6 | |
| 0.4 | 0.5 | 0.7 | 0.3 | 1.8 | 0.9 | 0.6 | 0.1 | 0.1 | 0.6 | 0.0 | 0.1 | 0.8 | |
| 30 | -6.7 | -263 | -74 | 27 | 7.1 | 32 | -14 | 18 | -129 | 69 | 26 | -17 | |
| – | – | – | – | – | – | – | – | – | 7.5 | – | – | – | |
| 11 | 4.8 | 319 | 17 | 0.6 | 0.6 | 0.0 | 0.9 | 0.1 | 112 | 11 | 42 | 166 | |
| 39 | -27 | 26 | -87 | -1.5 | -38 | -16 | -64 | -29 | 12 | 12 | -2.1 | -6.8 | |
| -1.6 | -25 | -30 | -31 | -31 | -47 | -48 | -43 | -46 | 28 | -68 | -70 | -157 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.